Placeholder Banner

BIO Names Stephanie Batchelor Vice President for Industrial & Environmental Section

July 2, 2019
Media Contact
Karen Batra
202.449.6382

“We have tremendous confidence in Stephanie’s abilities and leadership, having named her acting head of this section in April of this year, and we are thrilled that this appointment will be permanent,” said BIO President and CEO Jim Greenwood. “Across our members and within the broader BIO team, Stephanie is widely regarded as a go-to team player and a passionate advocate for the biotechnology-driven innovations developed by the companies within BIO’s industrial & environmental section.”

Stephanie has worked for BIO in the I&E section since July 2008 when she was director of state and international policy. Most recently, serving as the I&E section’s managing director, Stephanie helped guide the section’s strategic vision as it adopts a more focused and coordinated approach for advocacy and communications. 

During her tenure at BIO, Stephanie has created the Women in Industrial Biotech group, established and chaired the below50 USA chapter, secured renewable chemicals tax credits in three states, and participated on the advisory panel for the California low carbon fuel standard to ensure it was implemented in a way that incentivizes low carbon biofuels.

“Stephanie has been a vital member of the BIO team for several years,” said Hugh Welsh, president and general counsel of DSM North America and chair of BIO’s I&E section governing board. “As our industry continues to navigate a complex business and political environment, we are fortunate to have Stephanie helping to advance our sustainability goals and grow America’s bio-based economy.”

Before joining BIO, Stephanie worked with the European Economic and Social Committee and Women for Women International. Stephanie holds a master’s degree in international relations from New York University and a bachelor's degree in international politics and world history from the University at Albany, SUNY.

Discover More
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO),…